Year

2020

Status

Active

Team

 

Field

Thrombotic diseases

Location

Utrecht (Netherlands)

Fund

FIRST

TargED Biopharmaceuticals

TargED is developing a novel thrombolytic agent that has the potential to treat various thrombotic diseases, including Acute Ischemic Stroke.